Zafirah Salman, MD
Pulmonary Disease · North Little Rock, ARNPI 1003256835
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,899 of the $18,033 with a category attached, or 60.4%. 40 manufacturers reported payments, led by Intuitive Surgical at 31.1% of the total. 2025 is the largest year on record at $7,994, 3.1 times the $2,604 reported in 2019. Among pulmonary disease clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 549 payments — averaging $32.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Covidien LP$2K
- GSK$2K
- AstraZeneca$1K
- Boehringer Ingelheim$984
- Actelion Pharmaceuticals US, Inc.$788
- plus $5K from 34 others
What the payments were for
- Travel & lodging$2,83116%
- Food & beverage$10,89960%
- Education$4,30324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $5,607 |
| Covidien LP | 3 | $2,090 |
| GSK | 123 | $1,941 |
| AstraZeneca | 80 | $1,382 |
| Boehringer Ingelheim | 53 | $984 |
| Actelion Pharmaceuticals US, Inc. | 29 | $788 |
| Sanofi | 33 | $659 |
| United Therapeutics Corporation | 23 | $543 |
| Regeneron Healthcare Solutions, Inc. | 23 | $541 |
| Mylan Specialty L.p. | 23 | $396 |
| Insmed, Inc. | 17 | $319 |
| Baxter Healthcare | 10 | $273 |
| Genentech USA, Inc. | 11 | $267 |
| Grifols USA, LLC | 13 | $265 |
| Mallinckrodt Hospital Products Inc. | 8 | $224 |
| Electromed, Inc. | 16 | $213 |
| Sanofi-aventis U.S. LLC | 2 | $185 |
| Merck | 8 | $150 |
| AbbVie(2 entities) | 8 | $137 |
| Amgen | 6 | $114 |
| ANI Pharmaceuticals, Inc. | 5 | $110 |
| Philips North America LLC | 5 | $99 |
| Melinta Therapeutics, LLC | 4 | $96 |
| Pfizer | 6 | $95 |
| Johnson & Johnson | 6 | $95 |
| Astellas Pharma US Inc | 4 | $89 |
| Viatris Specialty LLC | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Bayer | 2 | $46 |
| Inogen, Inc. | 1 | $29 |
| Pulmonx Corporation | 1 | $29 |
| Sandoz | 2 | $24 |
| Tactile Systems Technology Inc | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| La Jolla Pharmaceutical Company | 1 | $16 |
| Vifor Pharma, Inc. | 1 | $16 |
| Nevro Corp. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Teleflex LLC | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,474
- superDimension$2,090
- UPTRAVI$121
- OPSUMIT$121
- AREXVY$116
How this compares
$18,033 in reported general payments places this provider in the 90th percentile of 102 pulmonary disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 203 | $148,305 |
| Dupixent PenDupilumab | 33 | $132,265 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 57 | $44,695 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 79 | $37,159 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 52 | $32,995 |
| EliquisApixaban | 24 | $29,882 |
| Breo ElliptaFluticasone/Vilanterol | 61 | $25,451 |
| Spiriva RespimatTiotropium Bromide | 44 | $24,881 |
| Incruse ElliptaUmeclidinium Bromide | 57 | $20,167 |
| Advair HfaFluticasone Propion/Salmeterol | 43 | $15,174 |
| Spiriva HandihalerTiotropium Bromide | 16 | $13,473 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $9,303 |
| Arnuity ElliptaFluticasone Furoate | 42 | $8,687 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 17 | $6,888 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 158 | $4,332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $1,941 | $239,770442 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,382 | $60,887105 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $984 | $57,87696 claims |
| PfizerEliquis | $95 | $29,88224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 102 pulmonary disease providers in Arkansas.
Other pulmonary disease in North Little Rock
- Dominika SzwedoNorth Little Rock$17K
- Hassan ZebNorth Little Rock$13K
- Muhammad AliNorth Little Rock$11K
- Ladly AbrahamConway$371K
- Daniel PaulRogers$244K
- Jason McKinneyRogers$86K
- Arturo MeadeFort Smith$67K
- Nikhil MeenaLittle Rock$63K
- Penchala MittadodlaRogers$21K
- Mark SiffordJonesboro$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.